Zeskind Benjamin J. 4
4 · Immuneering Corp · Filed Dec 27, 2022
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Zeskind Benjamin J.
DirectorPRESIDENT AND CEO
Transactions
- Exercise/Conversion
Class A Common Stock
2022-12-22$3.01/sh+2,500$7,525→ 2,261,852 total - Exercise/Conversion
Stock Option
2022-12-22−2,500→ 203,500 totalExercise: $3.01Exp: 2029-12-15→ Class A Common Stock (2,500 underlying)
Holdings
- 894,927(indirect: See Foonote)
Class A Common Stock
Footnotes (2)
- [F1]Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.
- [F2]The option has fully vested and is currently exercisable.